Paper Details
- Home
- Paper Details
Impact of daily use of emollient 'plus' on corticosteroid consumption in patients with atopic dermatitis: An open, randomized controlled study.
Author: Demessant-FlavignyA-L, KerobD, SalahS, ZelenkovaH
Original Abstract of the Article :
BACKGROUND: Emollients are the baseline treatment for mild or moderate atopic dermatitis (AD) to improve the epidermal barrier and provide anti-irritant and anti-pruritic effects. Emollient 'plus' can influence the skin microbiome of atopic eczema patients. OBJECTIVES: To evaluate the benefits of u...See full text at original site
Dr.Camel's Paper Summary Blogラクダ博士について
ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。
* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。
引用元:
https://doi.org/10.1111/jdv.18947
データ提供:米国国立医学図書館(NLM)
Emollient 'Plus': A Novel Approach to Atopic Dermatitis Management
This research investigates the potential of a novel emollient 'plus' formulation to reduce corticosteroid consumption in patients with atopic dermatitis (AD). The study, conducted in a randomized controlled trial, compared the effects of using emollient 'plus' twice daily for 28 days with the use of a standard emollient. The researchers found that the emollient 'plus' group demonstrated significantly lower corticosteroid consumption compared to the control group, while maintaining similar improvements in AD severity and quality of life.
Emollient 'Plus': A Corticosteroid-Sparing Option
This study highlights the potential of emollient 'plus' formulations as a corticosteroid-sparing option for managing atopic dermatitis (AD). The researchers observed a significant reduction in corticosteroid use in the emollient 'plus' group without compromising efficacy. This finding suggests that emollient 'plus' could offer a valuable alternative to traditional treatments for AD, potentially reducing the risks and side effects associated with long-term corticosteroid use.
Emollient 'Plus': A Holistic Approach to Atopic Dermatitis
This research underscores the importance of a holistic approach to managing atopic dermatitis (AD). The study suggests that incorporating emollient 'plus' formulations into treatment plans can help to reduce reliance on corticosteroids, potentially leading to fewer side effects and improved overall skin health. By addressing the underlying skin barrier dysfunction, emollient 'plus' formulations could provide a more comprehensive and sustainable approach to AD management.
Dr.Camel's Conclusion
The desert of skin conditions can be vast and unforgiving, but with the right tools, we can navigate its challenges with confidence. This research sheds light on the potential of emollient 'plus' formulations as a powerful tool for managing atopic dermatitis. By reducing corticosteroid dependence and improving skin barrier function, emollient 'plus' could offer a more holistic and effective approach to treating this chronic skin condition. Just as a camel adapts to the harsh desert environment, we can adapt our treatment strategies to achieve optimal skin health.
Date :
- Date Completed 2023-05-29
- Date Revised 2023-05-29
Further Info :
Related Literature
English
This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.